• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/11

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

11 Cards in this Set

  • Front
  • Back
Clinical Muir-Torre Syndrome
Inheritance
Autosomal dominant; MSH1 and MSH2 genes on 3p2l and 2p22 21, respectively
Prenatal
DNA analysis
Incidence
At least 65 cases reported; M=F
Age of Presentation
Fifth to sixth decade of life (internal malignancies usually precede cutaneous lesions)
Pathogenesis
Mutations in MSH2 (most common) and MSH 1, DNA mismatch repair genes, produces phenotype;

syndrome is linked to the Lynch II cancer family syndrome
Clinical
Skin
Multiple sebaceous tumors: adenomas (most common), carcinomas, hyperplasias, epitheliomas, basal cell carcinoma with sebaceous differentiation
Keratoacanthomas

Neoplasms
Adenocarcinoma of the colon (most common), other gastrointestinal tract, genitourinary tract, lung, breast, and hematologic malignancies described
DDx
Cowden syndrome
Gardner syndrome
Lab
Skin biopsy

Endoscopy/gastrointestinal

x ray
Management
Close follow up by internist screening for malignancy Referral to dermatologist Referral to gastroenterologist
Prognosis
Malignancies usually low grade with good prognosis; may have normal life span with close surveillance and early detection of malignancy